Following the occurrence of several hospital-acquired malaria cases in the European Union (EU), ECDC has assessed the risk related to transmission of the parasite in hospital settings.
Childhood immunisation against S. pneumoniae is the most effective public health measure for preventing IPD both among vaccine recipients (direct effect), and among unimmunised populations (indirect ‘herd’ effect).
On 31 August 2016 the autonomous Community of Madrid, Spain, reported two cases of infection with Crimean–Congo haemorrhagic fever (CCHF) virus. This document assesses the risk associated with the occurrence of two cases of Crimean–Congo haemorrhagic fever in Spain.
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
This document assesses the risk to human health posed by a multi-country foodborne outbreak of Shiga toxin-producing Escherichia coli (STEC) infections associated with haemolytic uraemic syndrome taking place in the European Union (EU).
This rapid risk assessment assesses the specific risk related to importation and spread of vector borne diseases in the context of a large number of migrants to the EU. It does not cover other health needs for these populations.
The European Parliament Committee on the Environment, Public Health and Food Safety held a meeting with the European Commission, ECDC and EFSA on the risks posed by food-borne Campylobacter bacteria and the possible control options.
Location:Brussels, Belgium
Organized by:European Parliament Committee on the Environment, Public Health and Food Safety
The ECDC risk, as assessed on 23 August 2011, remains unchanged. The main risk is to persons residing in, visiting and working in the affected areas of Greece, particularly Evrotas in Lakonia. The risk for further extension of malaria transmission into the EU as a result of this event is considered low at present. EU national blood competent authorities should be considering whether to implement deferral measures for persons returning from these specific affected areas in Greece, taking into consideration measures currently implemented by the Greek blood safety authorities and after a considered risk assessment in collaboration with their national public health authorities.